This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheung, M. C. Articles by Dezube, B. J. Search for Related Content PubMed PubMed Citation Articles by Cheung, M. C. Articles by Dezube, B. J.

AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy

^a Sunnybrook and Women’s College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; ^b Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts, USA; ^c Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Correspondence: Correspondence: Bruce Dezube, M.D., Beth Israel Deaconess Medical Center, 330 Brookline Avenue, CC-913, Boston, Massachusetts 02215, USA. Telephone: 617-667-7082; Fax: 617-975-5665; e-mail: bdezube{at}bidmc.harvard.edu

Human immunodeficiency virus (HIV)-infected patients are at increased risk of developing cancer, particularly in the later stages of acquired immune deficiency syndrome (AIDS). Despite the advent of highly active anti-retroviral therapy (HAART), malignancy in this population is a leading cause of morbidity and mortality. Kaposi’s sarcoma (KS) and AIDS-related non-Hodgkin’s lymphoma (ARL) are the most common AIDS-defining malignancies. AIDS-related KS varies from minimal to fulminant disease. Treatment decisions for AIDS-related KS are guided largely by the presence and extent of symptomatic disease. In addition to HAART, excellent treatments exist for both localized disease (topical gel, radiotherapy, and intralesional therapy) and advanced disease (liposomal anthracyclines, paclitaxel). Novel therapies that have become available to treat AIDS-related KS include angiogenesis inhibitors and antiviral agents. ARL comprises a heterogeneous group of malignancies. With the immune restoration afforded by HAART, standard-dose chemotherapies now can be safely administered to treat ARL with curative intent. The role of analogous treatments used in HIV-negative patients, including monoclonal antibodies and autologous stem cell transplantation, requires further clarification in HIV-positive patients. HIV-infected patients also appear to be at increased risk for developing certain non-AIDS-defining cancers, such as Hodgkin’s lymphoma and multiple myeloma. Although the optimal treatment of these neoplasms is at present uncertain, recent advances in chemotherapy, antiretroviral drugs, and supportive care protocols are allowing for more aggressive management of many of the AIDS-related cancers. This article provides an up-to-date review of the epidemiology, pathogenesis, clinical features, and treatment of various AIDS-related malignancies that are likely to be encountered by an oncologist practicing in the current HAART era.

Key Words. Kaposi’s sarcoma • HIV-infection • AIDS • Non-Hodgkin’s lymphoma • Hodgkin’s lymphoma • Multiple myeloma • Antiretroviral therapy

This article has been cited by other articles:

				H. D. Strickler Does HIV/AIDS Have a Biological Impact on the Risk of Human Papillomavirus-Related Cancers? J Natl Cancer Inst, August 19, 2009; 101(16): 1103 - 1105. [Full Text] [PDF]

				S. Rothschild, M. Dolder, B. Seifert, U. M. Lutolf, and I. F. Ciernik Radiation Therapy for HIV-Associated Diffuse Large Cell Non-Hodgkin Lymphoma J Int Assoc Physicians AIDS Care (Chic Ill), July 1, 2009; 8(4): 239 - 248. [Abstract] [PDF]

				J. Mitri, J. Castillo, and A. G. Pittas Diabetes and Risk of Non-Hodgkin's Lymphoma: A meta-analysis of observational studies Diabetes Care, December 1, 2008; 31(12): 2391 - 2397. [Abstract] [Full Text] [PDF]

				J.-P. Spano, D. Costagliola, C. Katlama, N. Mounier, E. Oksenhendler, and D. Khayat AIDS-Related Malignancies: State of the Art and Therapeutic Challenges J. Clin. Oncol., October 10, 2008; 26(29): 4834 - 4842. [Abstract] [Full Text] [PDF]

				J.-S. Kim, S. J. Kim, J.-S. Kim, E. S. Kim, H.-J. Shin, J. S. Chung, Y.-H. Min, M. H. Lee, Y. J. Choi, S.-M. Bang, et al. Report of Aids-related Lymphoma in South Korea Jpn. J. Clin. Oncol., February 8, 2008; (2008) hym168v1. [Abstract] [Full Text] [PDF]

				D. Pereg, G. Koren, and M. Lishner The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy Haematologica, September 1, 2007; 92(9): 1230 - 1237. [Abstract] [Full Text] [PDF]